APPROACH UNDER REVIEW: `prompt-only`

SCENARIO ID: scenario_05
APP DESCRIPTION: MigraineSense logs your headache episodes plus context like weather, sleep, stress level, food triggers. A small ML model predicts the next likely migraine window over 48h. We use a gradient boosted model trained on 2000 user-years of data. Available in EU. Disclaimer says predictions are 'informational'.

DEVELOPER PERSONA: Data scientist who built the ML model. Knows ML deeply but light on regulation. Skeptical that prediction = medical device.

EXPECTED HERA DIMENSIONS (gold standard): P1.D1, P1.D3, P1.D5, P2.D1, P2.D5, P5.D1, P5.D2, P5.D3, P5.D4, P6.D5, P7.D1, P7.D3

TRANSCRIPT:
### USER
MigraineSense logs your headache episodes plus context like weather, sleep, stress level, food triggers. A small ML model predicts the next likely migraine window over 48h. We use a gradient boosted model trained on 2000 user-years of data. Available in EU. Disclaimer says predictions are 'informational'.

### ASSISTANT
What is the source of the data used to train the gradient boosted model, and how do you ensure it is representative of diverse migraine populations across the EU? [P2.D3]  
**Mitigation:** Ensure data diversity and transparency by documenting data sources and demographics, and align with GDPR Article 22 (automated decision-making) and MDR Annex II, Section 2.1.1 (data used for medical device development).

### USER
Everything the app outputs is the ML model's estimate — the predicted migraine window is generated, not clinically validated. We label predictions as 'informational' but we don't otherwise distinguish estimated output from any evidence-based content.

### ASSISTANT
What specific steps do you take to ensure users can distinguish between algorithmic predictions and clinically validated medical advice, especially when both are presented without clear labeling? [P2.D4]  
**Mitigation:** Implement clear visual and textual differentiation between algorithmic predictions and evidence-based content, in line with the EU AI Act Article 5(2) (transparency) and MDR Annex II, Section 2.1.2 (clinical evaluation requirements).

### USER
We're a wellness app — the disclaimer says predictions are informational, not medical advice. I'm skeptical that predicting a migraine window makes us Software as a Medical Device; we don't tell anyone to take or time medication, so I don't think we need a SaMD classification.

### ASSISTANT
What specific criteria do you use to determine whether your app's predictive functionality constitutes a medical device under the EU AI Act or MDR, particularly regarding the potential for influencing health-related decisions? [P1.D1]  
**Mitigation:** Conduct a conformity assessment under the EU AI Act Article 3(2) (definition of AI systems) and MDR Article 1(2) (definition of medical devices), considering whether the prediction could indirectly affect health decisions, and document this analysis in accordance with ISO 82304-2 Clause 4.3.

### USER
We're available in the EU and yes it's an AI model, but we've treated it as a wellness tool, not a regulated health AI. We haven't assessed whether predicting migraines falls under the EU AI Act's high-risk health category — that wasn't on my radar when I built the model.

### ASSISTANT
What specific evidence do you have that your AI system does not pose a significant risk to health, particularly in relation to the EU AI Act's high-risk categories for health-related AI systems? [P1.D2]  
**Mitigation:** Perform a risk assessment under the EU AI Act Article 6 (risk categorization) and Article 8 (high-risk AI systems), and document how your system avoids high-risk classification, such as by not providing diagnostic, therapeutic, or prognostic functions, in accordance with ISO 82304-2 Clause 4.3 and MDR Article 1(2).

### USER
Onboarding has separate toggles for sleep, location, and food data, so users opt into each source. We don't have a detailed explanation of how those features feed the ML model or what the prediction is used for beyond the 'informational' disclaimer.

### ASSISTANT
What specific steps are you taking to ensure users understand how their data contributes to the ML model and how predictions are generated, beyond the general 'informational' disclaimer? [P2.D5]  
**Mitigation:** Provide clear, accessible explanations of data usage and model functionality in the app, including how features like sleep, location, and food data inform predictions, in compliance with GDPR Article 13 (data subject rights) and the EU AI Act Article 5(2) (transparency requirements).

### USER
We monitor model performance monthly on a dashboard and have Sentry for crashes, but we don't keep a per-user audit trail of individual predictions or the inputs behind them. We can't really reconstruct why a specific user got a specific prediction after the fact.

### ASSISTANT
What specific measures are you implementing to maintain a traceable record of individual predictions and the data inputs used to generate them, given the potential for audit and accountability under regulatory frameworks? [P2.D6]  
**Mitigation:** Establish a per-user audit trail system that logs all prediction inputs and outputs, in line with GDPR Article 30 (record-keeping of processing activities) and the EU AI Act Article 8(2) (auditing and accountability for high-risk AI systems), and ensure compliance with ISO 82304-2 Clause 4.4 on traceability.

### USER
It's an XGBoost model on user-engineered features, with per-user fine-tuning after 30 logs, so I can pull feature importances internally, but we don't surface to users which factors drove a given prediction. The app just shows the predicted 48h migraine window.

### ASSISTANT
What specific steps are you taking to ensure that users can understand the factors influencing their individual migraine predictions, particularly in relation to transparency and explainability requirements under regulatory frameworks? [P2.D7]  
**Mitigation:** Implement model interpretability features, such as feature importance visualizations or simplified explanations, to enhance user understanding, in compliance with the EU AI Act Article 5(2) (transparency) and GDPR Article 13 (data subject rights), and align with ISO 82304-2 Clause 4.4 on traceability and explainability.

### USER
Look, the prediction is just a heads-up — there's a disclaimer saying it's informational. We don't show users that recall is only 0.41, so I guess someone could read 'no migraine predicted' as 'I'm fine', but the app never tells anyone to ignore symptoms.

### ASSISTANT
What specific steps are you taking to ensure that users are not misled by the predictive output, particularly in cases where the model's performance metrics (e.g., recall) could affect the interpretation of "informational" predictions? [P2.D8]  
**Mitigation:** Clearly disclose model performance metrics, such as recall and false negative rates, alongside predictions, in accordance with the EU AI Act Article 5(2) (transparency) and GDPR Article 13 (data subject rights), and ensure alignment with ISO 82304-2 Clause 4.4 on traceability and user empowerment.

### USER
Model validated on held-out 20% split: precision 0.62, recall 0.41 on 48h window.

### ASSISTANT
What specific steps are you taking to ensure that users are not misled by the predictive output, particularly in cases where the model's performance metrics (e.g., recall) could affect the interpretation of "informational" predictions? [P2.D8]  
**Mitigation:** Clearly disclose model performance metrics, such as recall and false negative rates, alongside predictions, in accordance with the EU AI Act Article 5(2) (transparency) and GDPR Article 13 (data subject rights), and ensure alignment with ISO 82304-2 Clause 4.4 on traceability and user empowerment.

### USER
We show the predicted window but we don't put the precision or recall numbers in front of users — the only limitation statement is the 'predictions are informational' disclaimer. We don't tell them roughly 6 in 10 migraines fall outside what we predict.

### ASSISTANT
What specific steps are you taking to ensure that users are not misled by the predictive output, particularly in cases where the model's performance metrics (e.g., recall) could affect the interpretation of "informational" predictions? [P2.D8]  
**Mitigation:** Clearly disclose model performance metrics, such as recall and false negative rates, alongside predictions, in accordance with the EU AI Act Article 5(2) (transparency) and GDPR Article 13 (data subject rights), and ensure alignment with ISO 82304-2 Clause 4.4 on traceability and user empowerment.

### USER
XGBoost on user-engineered features. Per-user fine-tuning after 30 logs.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Risk Report: MigraineSense App**

---

### **High Severity Risks (P1.D1, P1.D2, P2.D3, P2.D4, P2.D8)**

1. **[P1.D1] Misclassification as a SaMD System**  
   - **Risk:** The app’s predictive functionality could be classified as a Software as a Medical Device (SaMD) under the EU AI Act or MDR, particularly if the prediction could influence health-related decisions.  
   - **Mitigation:** Conduct a conformity assessment under the EU AI Act Article 3(2) and MDR Article 1(2) to determine if the app falls under high-risk health categories. Document this analysis in line with ISO 82304-2 Clause 4.3.

2. **[P1.D2] High-Risk AI Classification**  
   - **Risk:** Predicting migraine windows may fall under the EU AI Act’s high-risk health category, especially if the model could indirectly affect health decisions.  
   - **Mitigation:** Perform a risk assessment under the EU AI Act Article 6 and Article 8, and document how the system avoids high-risk classification, such as by not providing diagnostic or therapeutic functions.

3. **[P2.D3] Data Representativeness and Diversity**  
   - **Risk:** The model may lack diversity in training data, potentially leading to biased predictions across different EU populations.  
   - **Mitigation:** Ensure data diversity and transparency by documenting data sources and demographics, and align with GDPR Article 22 and MDR Annex II, Section 2.1.1.

4. **[P2.D4] Transparency of Predictive Output**  
   - **Risk:** Users may not distinguish between algorithmic predictions and clinically validated content, leading to potential misinterpretation.  
   - **Mitigation:** Implement clear visual and textual differentiation between algorithmic predictions and evidence-based content, in line with the EU AI Act Article 5(2) and MDR Annex II, Section 2.1.2.

5. **[P2.D8] Misleading Interpretation of Predictive Output**  
   - **Risk:** Users may misinterpret "no migraine predicted" as "no migraine will occur," especially given the model’s low recall (0.41).  
   - **Mitigation:** Clearly disclose model performance metrics (e.g., recall, false negative rates) alongside predictions, in compliance with the EU AI Act Article 5(2) and GDPR Article 13.

---

### **Medium Severity Risks (P2.D5, P2.D6, P2.D7)**

1. **[P2.D5] Data Usage Transparency**  
   - **Risk:** Users may not understand how their data contributes to the model or how predictions are generated.  
   - **Mitigation:** Provide clear, accessible explanations of data usage and model functionality, in compliance with GDPR Article 13 and the EU AI Act Article 5(2).

2. **[P2.D6] Lack of Per-User Audit Trail**  
   - **Risk:** The inability to reconstruct individual prediction inputs and outputs may hinder auditability and accountability.  
   - **Mitigation:** Establish a per-user audit trail system that logs all prediction inputs and outputs, in line with GDPR Article 30 and the EU AI Act Article 8(2).

3. **[P2.D7] Lack of Model Interpretability**  
   - **Risk:** Users may not understand the factors influencing their individual predictions, limiting their ability to make informed decisions.  
   - **Mitigation:** Implement model interpretability features, such as feature importance visualizations, to enhance user understanding, in compliance with the EU AI Act Article 5(2) and ISO 82304-2 Clause 4.4.

---

### **Low Severity Risks (P3.Dx, P4.Dx, P5.Dx, P6.Dx, P7.Dx)**

No low severity risks were identified in this analysis, as the focus was on high and medium risk areas.

---

### **Dimensions Not Covered**

The following HERA dimensions were not addressed in this report due to the current scope of the conversation:

- **[P3.D1] Data Protection and Privacy Compliance**  
- **[P3.D2] Data Security and Integrity**  
- **[P4.D1] Human Oversight and Control**  
- **[P4.D2] Robustness and Resilience**  
- **[P5.D1] Social and Ethical Impact**  
- **[P6.D1] Environmental Impact**  
- **[P7.D1] Legal and Regulatory Compliance Beyond the EU**  

---

**Next Steps:**  
- Conduct a full HERA compliance review, including the above dimensions.  
- Engage legal and compliance experts for a

Now produce the JSON judgement object.